Miss Manners: I am proud of my weight loss, but everyone thinks I’m using new drugs
DEAR MISS MANNERS: I am a 42-year-old woman who has been working hard to get healthier for myself…
Corps updates physical fitness test standards for combat MOS Marines
The U.S. Marine Corps is slated to implement a sex-neutral physical fitness test scoring system for Marines with…
Meta urged by state AGs to regulate weight loss drug ads
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
Ultra-processed foods damage health in ways that calories don’t explain
Researchers are getting closer to solving the riddle of how ultra-processed foods (UPFs) harm metabolic, reproductive, and immune…
GLP-1s, taste and what’s happening to our diets
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Single-cell RNA-seq reveals FBLN7’s role in adipose tissue fibrosis
Fibrosis, resulting from excess extracellular matrix (ECM) deposition, is a feature of adipose tissue (AT) dysfunction and obesity-related insulin resistance.…
Eli Lilly’s Weight Loss Superdrug Worked So Well During Trials, Some Quit Over Losing Too Much
There might soon be a new weight loss treatment king on top. This week, Eli Lilly posted the…
Sleeping less than 7 hours a night may shorten your life, new study warns
Americans who routinely sleep less than seven hours a night may be shortening their lives, results published in…
Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how…
Do they affect gut health? – The Irish Times
Walk into a supermarket, and much of what you see – breakfast cereals, frozen meals, processed meats –…
Hotter days and nights are already stealing sleep across the U.S.
Using more than 12 million nights of wearable sleep data, researchers show that warmer days and nights already…
BioAge shows promise with new drug BGE-102 in early trial
The company expands its Phase 1 trial after early signals show BGE-102’s potential to address inflammation beyond the…